Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Michael Diamond and Herbert Virgin.
Michael Diamond
Connection Strength
1.006
Herbert Virgin
  1. After the pandemic: perspectives on the future trajectory of COVID-19. Nature. 2021 08; 596(7873):495-504.
    View in: PubMed
    Score: 0.239
  2. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat Med. 2021 04; 27(4):717-726.
    View in: PubMed
    Score: 0.233
  3. Oral Antibiotic Treatment of Mice Exacerbates the Disease Severity of Multiple Flavivirus Infections. Cell Rep. 2018 03 27; 22(13):3440-3453.e6.
    View in: PubMed
    Score: 0.190
  4. 2'-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and -independent mechanisms of host restriction in vivo. PLoS Pathog. 2012; 8(5):e1002698.
    View in: PubMed
    Score: 0.127
  5. Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms. Science. 2020 11 20; 370(6519):950-957.
    View in: PubMed
    Score: 0.057
  6. Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2. Cell Host Microbe. 2020 09 09; 28(3):475-485.e5.
    View in: PubMed
    Score: 0.056
  7. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature. 2020 07; 583(7815):290-295.
    View in: PubMed
    Score: 0.055
  8. WDFY4 is required for cross-presentation in response to viral and tumor antigens. Science. 2018 11 09; 362(6415):694-699.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.